These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26098477)

  • 21. Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial.
    Ikramuddin S; Korner J; Lee WJ; Bantle JP; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Wang Q; Jeffery RW; Chong K; Chuang LM; Jensen MD; Vella A; Ahmed L; Belani K; Olofson AE; Bainbridge HA; Billington CJ
    Diabetes Care; 2016 Sep; 39(9):1510-8. PubMed ID: 27311493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
    Chow CC; Tsang LW; Sorensen JP; Cockram CS
    Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.
    Kosaka K; Noda M; Kuzuya T
    Diabetes Res Clin Pract; 2005 Feb; 67(2):152-62. PubMed ID: 15649575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.
    Erdman DM; Cook CB; Greenlund KJ; Giles WH; El-Kebbi I; Ryan GJ; Gallina DL; Ziemer DC; Dunbar VG; Phillips LS
    Diabetes Care; 2002 Jan; 25(1):9-15. PubMed ID: 11772894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions.
    Barry E; Roberts S; Oke J; Vijayaraghavan S; Normansell R; Greenhalgh T
    BMJ; 2017 Jan; 356():i6538. PubMed ID: 28052845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Study of Effects of Pioglitazone and Rosiglitazone on Various Parameters in Patients of Type-2 Diabetes Mellitus with Special Reference to Lipid Profile.
    Sharma SK; Verma SH
    J Assoc Physicians India; 2016 Sep; 64(9):24-28. PubMed ID: 27762511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.
    Moses R; Slobodniuk R; Boyages S; Colagiuri S; Kidson W; Carter J; Donnelly T; Moffitt P; Hopkins H
    Diabetes Care; 1999 Jan; 22(1):119-24. PubMed ID: 10333912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of use of metformin and replacement of starch with saturated fat in diets of patients with type 2 diabetes.
    Hays JH; Gorman RT; Shakir KM
    Endocr Pract; 2002; 8(3):177-83. PubMed ID: 12113629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Head-to-head comparison of intensive lifestyle intervention (U-TURN) versus conventional multifactorial care in patients with type 2 diabetes: protocol and rationale for an assessor-blinded, parallel group and randomised trial.
    Ried-Larsen M; Christensen R; Hansen KB; Johansen MY; Pedersen M; Zacho M; Hansen LS; Kofoed K; Thomsen K; Jensen MS; Nielsen RO; MacDonald C; Langberg H; Vaag AA; Pedersen BK; Karstoft K
    BMJ Open; 2015 Dec; 5(12):e009764. PubMed ID: 26656025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sweeteners and beta-glucans improve metabolic and anthropometrics variables in well controlled type 2 diabetic patients.
    Reyna NY; Cano C; Bermúdez VJ; Medina MT; Souki AJ; Ambard M; Nuñez M; Ferrer MA; Inglett GE
    Am J Ther; 2003; 10(6):438-43. PubMed ID: 14624282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a 12-week aerobic training on glycemic control in type 2 diabetes mellitus male patients.
    Tomar RH; Hashim MH; Al-Qahtani MH
    Saudi Med J; 2013 Jul; 34(7):757-9. PubMed ID: 23860898
    [No Abstract]   [Full Text] [Related]  

  • 33. ROSSO-in-praxi: a self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus.
    Kempf K; Kruse J; Martin S
    Diabetes Technol Ther; 2010 Jul; 12(7):547-53. PubMed ID: 20597830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials.
    Franz MJ; Boucher JL; Rutten-Ramos S; VanWormer JJ
    J Acad Nutr Diet; 2015 Sep; 115(9):1447-63. PubMed ID: 25935570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.
    de Ritter R; Sep SJS; van der Kallen CJH; Schram MT; Koster A; Kroon AA; van Greevenbroek MMJ; Eussen SJPM; Dagnelie PC; de Jong M; Vos RC; Woodward M; Bots ML; Peters SAE; Stehouwer CDA
    BMJ Open Diabetes Res Care; 2019; 7(1):e000787. PubMed ID: 31798903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes Self-Management Education and Medical Nutrition Therapy: A Multisite Study Documenting the Efficacy of Registered Dietitian Nutritionist Interventions in the Management of Glycemic Control and Diabetic Dyslipidemia through Retrospective Chart Review.
    Marincic PZ; Salazar MV; Hardin A; Scott S; Fan SX; Gaillard PR; Wyatt C; Watson L; Green P; Glover P; Hand M
    J Acad Nutr Diet; 2019 Mar; 119(3):449-463. PubMed ID: 30219311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation.
    Herman WH; Pan Q; Edelstein SL; Mather KJ; Perreault L; Barrett-Connor E; Dabelea DM; Horton E; Kahn SE; Knowler WC; Lorenzo C; Pi-Sunyer X; Venditti E; Ye W;
    Diabetes Care; 2017 Dec; 40(12):1668-1677. PubMed ID: 29021207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.
    Goldberg RB; Temprosa M; Mele L; Orchard T; Mather K; Bray G; Horton E; Kitabchi A; Krakoff J; Marcovina S; Perreault L; White N;
    Metabolism; 2016 May; 65(5):764-775. PubMed ID: 27085783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin, Lifestyle Intervention, and Cognition in the Diabetes Prevention Program Outcomes Study.
    Luchsinger JA; Ma Y; Christophi CA; Florez H; Golden SH; Hazuda H; Crandall J; Venditti E; Watson K; Jeffries S; Manly JJ; Pi-Sunyer FX;
    Diabetes Care; 2017 Jul; 40(7):958-965. PubMed ID: 28500216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.